A single-blind, randomized, placebo controlled phase I study to investigate the effect of single oral doses of AZD1175 with and without food on safety, tolerability and pharmacokinetics

Study identifier:D1740C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A single-blind, randomized, placebo controlled phase I study to investigate the effect of single oral doses of AZD1175 with and without food on safety, tolerability and pharmacokinetics

Medical condition

hypertension

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jul 2006
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria